FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097716036> ?p ?o ?g. }

• W2097716036 endingPage "625" @default.
• W2097716036 startingPage "617" @default.
• W2097716036 abstract "To evaluate the pattern of failure and outcome of patients with aggressive non-Hodgkin's lymphoma (NHL) undergoing high-dose chemotherapy (HDCT) and autologous stem cell rescue (SCR) with an emphasis on the role of adjuvant involved-field radiotherapy (IFRT).Fifty-three adult patients with aggressive NHL (46 intermediate-and 7 high-grade) underwent HDCT with SCR. All patients underwent induction chemotherapy prior to high dose intensification. Seven (13.2%) received IFRT to 10 disease sites either prior to or following HDCT. Indication included symptomatic or bulky disease, persistent disease, or to consolidate a complete response (CR). Sites of relapse were designated as old (involved prior to HDCT) or new (previously uninvolved). Median followup was 20.1 months (range, 1.2-69.3 months).The 4-year actuarial progression-free (PFS) and cause-specific (CSS) survivals of the entire group were 30.0 and 50.2%, respectively. Excluding toxic deaths, 24 patients (52.2%) relapsed. Sixteen (34.7%) failed in old and 15 (32.6%) in new sites. Patients treated with IFRT had a lower rate of relapse in old sites (0 vs. 41%) (p = 0.04) than patients treated with HDCT alone. Of the 141 sites present prior to induction, 127 (90.1%) were amenable to IFRT. Excluding irradiated sites, the overall 4-year local control (LC) of all amenable sites was 61.1%. Amenable sites failing to achieve a CR to induction had a poorer LC (32.0 vs. 95.1%) (p < 0.0001) than sites in CR. The 4-year LC of sites failing to achieve a CR to HDCT was 29.4%. Adjuvant IFRT improved the 4-year LC of all sites (100 vs. 61.1%) (p = 0.05), persistent sites following induction (100 vs. 32.0%) (p = 0.01) and persistent sites following HDCT (100 vs. 29.4%) (p = 0.01). Adjuvant IFRT was not associated with any untoward acute or late toxicity.The predominant site of relapse in patients with aggressive NHL undergoing HDCT and SCR is in sites of disease present prior to HDCT. However, the risk of relapse of prior disease sites varies greatly depending upon their response to chemotherapy. Sites at greatest risk are those failing to achieve a CR to induction regardless of their response to HDCT. IFRT is capable of reducing the high risk of relapse in these sites, the majority of which are amenable to IFRT. These results demonstrate a rationale for and possible benefit to IFRT in patients with aggressive NHL undergoing HDCT and SCR." @default.
• W2097716036 created "2016-06-24" @default.
• W2097716036 creator A5003454331 @default.
• W2097716036 creator A5008423688 @default.
• W2097716036 creator A5045138959 @default.
• W2097716036 date "1997-10-01" @default.
• W2097716036 modified "2023-10-02" @default.
• W2097716036 title "High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: Pattern of failure and implications for involved-field radiotherapy" @default.
• W2097716036 cites W1510444283 @default.
• W2097716036 cites W1604637468 @default.
• W2097716036 cites W1768406053 @default.
• W2097716036 cites W1807744984 @default.
• W2097716036 cites W1818726713 @default.
• W2097716036 cites W1846446924 @default.
• W2097716036 cites W1864883520 @default.
• W2097716036 cites W1877303819 @default.
• W2097716036 cites W1896652710 @default.
• W2097716036 cites W1911320760 @default.
• W2097716036 cites W1911976151 @default.
• W2097716036 cites W1937538988 @default.
• W2097716036 cites W1968736887 @default.
• W2097716036 cites W1971627173 @default.
• W2097716036 cites W1993171804 @default.
• W2097716036 cites W2006178875 @default.
• W2097716036 cites W2028919426 @default.
• W2097716036 cites W2038252831 @default.
• W2097716036 cites W2088798617 @default.
• W2097716036 cites W2103059515 @default.
• W2097716036 cites W2145917992 @default.
• W2097716036 cites W2219538991 @default.
• W2097716036 cites W2225927535 @default.
• W2097716036 cites W2253580546 @default.
• W2097716036 cites W2255094305 @default.
• W2097716036 cites W2267537115 @default.
• W2097716036 cites W2273109191 @default.
• W2097716036 cites W2273212049 @default.
• W2097716036 cites W2283063515 @default.
• W2097716036 cites W2313423582 @default.
• W2097716036 cites W2318258374 @default.
• W2097716036 cites W2338377114 @default.
• W2097716036 cites W2339381415 @default.
• W2097716036 cites W2396387671 @default.
• W2097716036 cites W2404815727 @default.
• W2097716036 cites W321206321 @default.
• W2097716036 doi "https://doi.org/10.1016/s0360-3016(97)00379-9" @default.
• W2097716036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9336141" @default.
• W2097716036 hasPublicationYear "1997" @default.
• W2097716036 type Work @default.
• W2097716036 sameAs 2097716036 @default.
• W2097716036 citedByCount "39" @default.
• W2097716036 countsByYear W20977160362012 @default.
• W2097716036 countsByYear W20977160362015 @default.
• W2097716036 countsByYear W20977160362016 @default.
• W2097716036 countsByYear W20977160362017 @default.
• W2097716036 countsByYear W20977160362018 @default.
• W2097716036 countsByYear W20977160362019 @default.
• W2097716036 countsByYear W20977160362020 @default.
• W2097716036 countsByYear W20977160362021 @default.
• W2097716036 crossrefType "journal-article" @default.
• W2097716036 hasAuthorship W2097716036A5003454331 @default.
• W2097716036 hasAuthorship W2097716036A5008423688 @default.
• W2097716036 hasAuthorship W2097716036A5045138959 @default.
• W2097716036 hasConcept C126322002 @default.
• W2097716036 hasConcept C141071460 @default.
• W2097716036 hasConcept C143998085 @default.
• W2097716036 hasConcept C2776611710 @default.
• W2097716036 hasConcept C2776694085 @default.
• W2097716036 hasConcept C2779338263 @default.
• W2097716036 hasConcept C509974204 @default.
• W2097716036 hasConcept C71924100 @default.
• W2097716036 hasConceptScore W2097716036C126322002 @default.
• W2097716036 hasConceptScore W2097716036C141071460 @default.
• W2097716036 hasConceptScore W2097716036C143998085 @default.
• W2097716036 hasConceptScore W2097716036C2776611710 @default.
• W2097716036 hasConceptScore W2097716036C2776694085 @default.
• W2097716036 hasConceptScore W2097716036C2779338263 @default.
• W2097716036 hasConceptScore W2097716036C509974204 @default.
• W2097716036 hasConceptScore W2097716036C71924100 @default.
• W2097716036 hasIssue "3" @default.
• W2097716036 hasLocation W20977160361 @default.
• W2097716036 hasLocation W20977160362 @default.
• W2097716036 hasOpenAccess W2097716036 @default.
• W2097716036 hasPrimaryLocation W20977160361 @default.
• W2097716036 hasRelatedWork W2023463542 @default.
• W2097716036 hasRelatedWork W2082691227 @default.
• W2097716036 hasRelatedWork W2089609493 @default.
• W2097716036 hasRelatedWork W2392262560 @default.
• W2097716036 hasRelatedWork W2413478001 @default.
• W2097716036 hasRelatedWork W2416632858 @default.
• W2097716036 hasRelatedWork W2441050612 @default.
• W2097716036 hasRelatedWork W2462005566 @default.
• W2097716036 hasRelatedWork W2564517819 @default.
• W2097716036 hasRelatedWork W2997709950 @default.
• W2097716036 hasVolume "39" @default.
• W2097716036 isParatext "false" @default.
• W2097716036 isRetracted "false" @default.
• W2097716036 magId "2097716036" @default.
• W2097716036 workType "article" @default.